| Biogen second-quarter profit rises |
| Reuters - 22 Jul 14:00 |
| Shareholders overwhelmingly approve Biogen board |
| Reuters - 10 Jul 06:00 |
| Icahn associate says Biogen has won proxy fight |
| Reuters - 19 Jun 16:03 |
| Biogen favored to win against Icahn in proxy fight |
| Reuters - 15 Jun 21:20 |
| Icahn challenges Biogen on effort to sell itself |
| Reuters - 5 Jun 15:40 |
| Genentech, Biogen say Rituxan fails in lupus study |
| Reuters - 29 Apr 16:20 |
| Battle looms at Biogen as Icahn seeks board seats |
| Reuters - 28 Jan 21:40 |
| Pfizer, Sanofi, J&J may be among Biogen bidders |
| Reuters - 15 Oct 23:01 |
| Pfizer, Sanofi, J&J may be among Biogen bidders |
| Reuters - 15 Oct 22:41 |
| Pfizer, Sanofi, J&J may be among Biogen bidders |
| Reuters - 15 Oct 16:02 |
| Biogen quarterly profit rises on higher drug sales |
| Reuters - 15 Feb 14:24 |
| Biogen profit rises on higher drug sales |
| Reuters - 15 Feb 14:06 |
| UCB sluit contract met Biogen Idec |
| Belegger.nl - 3 Oct 10:24 |
| Biogen posts second quarter loss |
| Reuters - 26 Jul 14:42 |
| Biogen reports loss on deal-related costs |
| Reuters - 26 Jul 14:00 |
| Elan, Biogen say FDA to extend review on Tysabri |
| Reuters - 22 Mar 23:06 |
| Elan, Biogen say FDA to extend review on Tysabri |
| Reuters - 22 Mar 13:30 |
| Biogen profit nearly doubles, eyes Tysabri return |
| Reuters - 16 Feb 06:00 |
| Biogen 4th-qtr profit nearly doubles |
| Reuters - 15 Feb 22:54 |
| Biogen quarterly profit rises on higher drug sales |
| Reuters - 15 Feb 22:24 |
Wie brengt u deze website? Dirk Dijksma's profile